Trump Expands Medicaid Drug Price Deal to All 50 States as Vance Stumps in Iowa With GOP Races Tightening

President Trump plans to announce Friday that the administration's Medicaid most-favored-nation pricing model will now apply in all 50 states, the District of Columbia, and Puerto Rico, according to a White House official cited by Reuters. Semafor first reported the move earlier Friday.

The pitch is simple: America pays more for prescription drugs than any other developed country, sometimes nearly three times as much, according to Reuters. Trump wants U.S. prices tied to whatever the lowest price is anywhere else in the world.

This builds on deals the administration has been signing with drugmakers since last fall. Reuters counts 17 of the largest global pharma companies, including Pfizer, Eli Lilly and Novo Nordisk, already on board. On Aug. 31, Trump added nine more midsize companies in the Oval Office: Alcon, Astellas Pharma, BeOne Medicines, BridgeBio, CSL, Kyowa Kirin, Sun Pharma, Teva Pharmaceuticals, and UCB, according to Breitbart and the Epoch Times. That brought the total to 26 companies covering close to 90% of the branded drug market, per the White House.

The companies collectively committed $19.6 billion toward U.S. manufacturing, the White House said. BeOne Medicines Chairman John Oyler told the Epoch Times his company alone will invest nearly $11 billion in U.S. research and manufacturing through 2029. Kyowa Kirin President Steve Schaefer said his company will shift so that more than 95% of its U.S.-manufactured drugs go to American patients within two years.

Medicaid already gets steep drug discounts mandated by existing federal law, and Reuters notes most Medicaid enrollees already pay little out of pocket for prescriptions. The practical savings from Friday's expansion, while real for state Medicaid budgets, may be smaller than the White House's billions-in-savings framing suggests for the people actually filling prescriptions. The deals are also voluntary corporate commitments, not binding statute, so their durability depends on the companies continuing to honor them.

Fox News's coverage leaned into the political contrast, running commentary from Fox Business analyst Taylor Riggs pairing the drug deal against a separate report estimating $200 trillion in costs for programs like Medicare for All. Trump made that same comparison directly, telling NTD that a government-run alternative "would have to quadruple taxes," while calling his own approach "much bigger, much better, much less expensive."

Vance in Iowa as the midterm map shifts

Vice President Vance headlined a rally Friday in Council Bluffs, Iowa, his second trip to the state this year, according to the Associated Press. He appeared alongside Zach Lahn, the Republican nominee for governor running against Democratic State Auditor Rob Sand. Rep. Ashley Hinson, the Republican Senate nominee, skipped the event, her campaign told the AP, citing previously scheduled commitments.

Council Bluffs is home turf for Josh Turek, the Democratic state legislator running against Hinson for Iowa's open Senate seat, per the AP. Democratic Congressional Campaign Committee spokesperson Katie Smith said Iowans "have had enough of their D.C.-first, Iowa last priorities" and blamed Republicans for rising costs at the pump, grocery store and doctor's office.

A Hill/Emerson College poll released Friday found Kansas Democratic Senate candidate Adam Hamilton leading Republican Sen. Roger Marshall 45% to 43%, a race in a state Republicans have long taken for granted. The Washington Post reported Democrats are increasingly confident about a broader wave, citing strong post-Labor Day polling in battlegrounds and even traditionally red areas, alongside near-record unpopularity numbers for Trump.

The Post also tied rising gas prices to recent escalation in the war in Iran, including an attack on a major pipeline in Saudi Arabia, arguing that dynamic will keep pressure on pump prices through the fall. The AP separately noted that Iowa Republican Reps. Zach Nunn and Mariannette Miller-Meeks joined a symbolic House vote this week to halt the Iran conflict, a sign the war Trump launched is creating friction within his own party ahead of November.

Vance has also been building a parallel message on government fraud. At an earlier Kansas City, Missouri, event, he touted his chairmanship of the White House Task Force to Eliminate Fraud, telling reporters his effort has stopped $260 million in Medicaid payments to Minnesota and uncovered $6.3 billion in contracting fraud, according to the Daily Signal. Those figures come from the White House itself; no independent audit or court finding confirming the underlying fraud allegations was cited in available reporting, and the Minnesota payment freeze remains tied to allegations rather than a completed enforcement action.

Trump's drug pricing rollout and Vance's travel schedule could blunt the cost-of-living argument Democrats are running on, or gas prices tied to the Iran conflict may outweigh both as voters head into early voting.